Clinical Trials · NCT00254800
The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 38
- Start date
- Nov 2005
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Assessment of Pharmacokinetics profile of exenatide measured by AUC and Cmax